Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001445815-24-000005
Filing Date
2024-01-16
Accepted
2024-01-16 10:09:33
Documents
1
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 3088
  Complete submission text file 0001445815-24-000005.txt   4910
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Issuer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BIOXYTRAN, INC 233 NEEDHAM ST., SUITE 300 NEWTON MA 02464
Business Address
Utter Anders (Reporting) CIK: 0001818430 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-35027 | Film No.: 24533995